BRIEF published on 04/15/2025 at 15:45, 1 year 4 months ago Clean Air Metals Expands High-Grade Resource at Thunder Bay North High-grade Mineralization Drilling Results Clean Air Metals Thunder Bay North PGE-Cu-Ni
BRIEF published on 04/15/2025 at 15:45, 1 year 4 months ago Clean Air Metals étend ses ressources à haute teneur à Thunder Bay North Minéralisation À Haute Teneur Résultats De Forage Thunder Bay Nord PGE-Cu-Ni Métaux Pour Un Air Pur
BRIEF published on 04/15/2025 at 15:35, 1 year 4 months ago Jaguar Health's Promising Results for Breast Cancer Patients at MASCC Annual Meeting Crofelemer Jaguar Health Breast Cancer Supportive Care FDA Discussions
BRIEF published on 04/15/2025 at 15:35, 1 year 4 months ago Résultats prometteurs de Jaguar Health pour les patientes atteintes d'un cancer du sein lors de la réunion annuelle du MASCC Crofelemer Jaguar Health Cancer Du Sein Soins De Soutien Discussions De La FDA
BRIEF published on 04/15/2025 at 15:14, 1 year 4 months ago JPMorgan Chase Reduces Stake in Dalata Hotel Group Voting Rights Dalata Hotel Group Financial Notification JPMorgan Chase Equity Stakes
BRIEF published on 04/15/2025 at 15:14, 1 year 4 months ago JPMorgan Chase réduit sa participation dans le groupe hôtelier Dalata Droit De Vote Notification Financière Groupe Hôtelier Dalata JPMorgan Chase Participations En Capital
BRIEF published on 04/15/2025 at 15:05, 1 year 4 months ago RE Royalties Announces Q1 2025 Dividend Renewable Energy Shareholder Value Dividend Announcement Financial Strategy Quarterly Performance
BRIEF published on 04/15/2025 at 15:05, 1 year 4 months ago RE Royalties annonce son dividende pour le premier trimestre 2025 Énergie Renouvelable Stratégie Financière Valeur Actionnariale Annonce De Dividendes Performance Trimestrielle
BRIEF published on 04/15/2025 at 15:05, 1 year 4 months ago Tharimmune Enhances Board with Vincent LoPriore Appointment Biotechnology Board Appointment Financial Strategy Tharimmune Vincent LoPriore
BRIEF published on 04/15/2025 at 15:05, 1 year 4 months ago Tharimmune renforce son conseil d'administration avec la nomination de Vincent LoPriore Biotechnologie Stratégie Financière Nomination Au Conseil D'administration Tharimmune Vincent LoPriore
Published on 09/11/2026 at 21:25, 29 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 4 hours 54 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 4 hours 54 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 6 hours 29 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours 54 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 19:44, 2 hours 9 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 3 hours 39 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 3 hours 54 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 14 hours 54 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 14 hours 54 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 14 hours 54 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 14 hours 54 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 2 hours ago Availability of the 2026 Interim Financial Report
